VISTAGEN THERAPEUTICS, INC. Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums
VISTAGEN THERAPEUTICS, INC. (VTGN) had Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums of $1.18 million as of 2014-12-31, per its 10-Q filed 2015-02-17.
Discontinued › Notes
us-gaap:UnamortizedLoanCommitmentAndOriginationFeesAndUnamortizedDiscountsOrPremiums · last filed 2015-02-17
- 2014-12-31: Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums $1.18M.
- 2014-03-31: Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums $697.40K.
| Period end | Unamortized Loan Commitment and Origination Fees and Unamortized Discounts or Premiums |
|---|---|
| 2014-12-31 | $1.18M 10-Q · filed 2015-02-17 |
| 2014-03-31 | $697.40K 10-Q · filed 2015-02-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |